NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
Stanford University
Icahn School of Medicine at Mount Sinai
University of California, San Francisco
M.D. Anderson Cancer Center
Cancer Trials Ireland
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center